Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IscAlert

Financiado

Cerrado

A Breakthrough Biomedical Sensor for the Continuous Real Time Detection of Ische...

A Breakthrough Biomedical Sensor for the Continuous Real Time Detection of Ischemia a Contributor in over 10 million Annual Deaths Globally Sensocure is an ambitious Norwegian company, established in 2011, to commercialise IscAlert, the World's first implantable micro sensor for the early detection of ischemia. Ischemia is a restriction in blood supply to tissues,... ver más

31/10/2023

UNIVERSITY OF SOUT...

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

UNIVERSITETET I SOROST-NORGE No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-10-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

UNIVERSITY OF SOUTH-EASTERN...

1.96M€ | Lider

SAITEC OFFSHORE TECHNOLOGIES

185.74K€ | Participante

Proyectos interesantes

V-LAP

Medical Technol...

Data Science

3M€ Cerrado

RSENSE4Health

Medical Technol...

Data Science

100K€ Cerrado

PTQ-12-05805

Medical Technol...

Data Science

78K€ Cerrado

PTQ2023-013156

Medical Technol...

Data Science

109K€ Cerrado

PTQ2021-012005

Medical Technol...

Data Science

100K€ Cerrado

TEC2011-22746

Medical Technol...

Data Science

57K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 36 meses Fecha Inicio: 2020-10-15
Fecha Fin: 2023-10-31

Líder del proyecto

UNIVERSITETET I SOROST-NORGE No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Sensocure is an ambitious Norwegian company, established in 2011, to commercialise IscAlert, the World's first implantable micro sensor for the early detection of ischemia. Ischemia is a restriction in blood supply to tissues, causing a shortage of oxygen, nutrients and inadequate removal of metabolic waste, eventually leading to cell death. Ischemia is suffered by 30m people globally every year, 10m of whom unfortunately lose their lives. Ischemia is highly preventable if it can be detected early. Unfortunately existing detection solutions simply cannot provide the early, accurate and real time monitoring required by surgeons and healthcare organisations. In contrast, IscAlert is a user friendly, fast, robust and cost effective real-time monitoring system. It conforms to current medical practice, improves patient outcomes and substantially reduced healthcare costs e.g. less corrective surgery and need for intensive care. We have made significant progress in the past 18 months. Following the completion of pre-clinical trials of the TRL6 sensor in 2018, Sensocure has now completed a TRL7 version of the IscAlert sensor. This design is smaller, cheaper and significantly more sensitive than the previous version. We now need to embark upon our next and final steps towards commercialisation; completing clinical trials, gaining Class II CE Marking medical device approval for sale in Europe and scaling up our production processes. Following the EIC Accelerator project, we will seek €3.5million in equity investment from the EC. This will allow us to scale operations and undertake FDA approval for sales in US markets. By 2027, we will employ an additional 113 staff, annual sales of 38,000 sensors, and have generated total accrued revenues of €59.92m and profits €16.95m. Market success will save lines and improve patient outcomes, delivering savings to healthcare providers of €102m p.a. and freeing up 18,300 hospital days.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores